Dr. Martens plc
DOCMF · OTC
9/30/2025 | 3/31/2025 | 3/30/2025 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | – | $0 | $0 |
| % Growth | – | – | 42.6% | – |
| Cost of Goods Sold | $0 | – | $0 | $0 |
| Gross Profit | $0 | – | $0 | $0 |
| % Margin | 54.6% | – | 65.7% | 64% |
| R&D Expenses | $0 | – | $0 | $0 |
| G&A Expenses | $0 | – | $0 | $0 |
| SG&A Expenses | $0 | – | $0 | $0 |
| Sales & Mktg Exp. | $0 | – | $0 | $0 |
| Other Operating Expenses | $0 | – | $0 | $0 |
| Operating Expenses | $0 | – | $0 | $0 |
| Operating Income | $0 | – | $0 | -$0 |
| % Margin | 1% | – | 15.4% | -4.7% |
| Other Income/Exp. Net | -$0 | – | -$0 | -$0 |
| Pre-Tax Income | -$0 | – | $0 | -$0 |
| Tax Expense | -$0 | – | $0 | -$0 |
| Net Income | -$0 | – | $0 | -$0 |
| % Margin | -3.1% | – | 5.5% | -6.4% |
| EPS | -0.014 | – | 0.034 | -0.022 |
| % Growth | – | – | 254.5% | – |
| EPS Diluted | -0.014 | – | 0.034 | -0.022 |
| Weighted Avg Shares Out | 1 | – | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | – | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | – | $0 | $0 |
| Interest Expense | $0 | – | $0 | $0 |
| Depreciation & Amortization | $0 | – | $0 | $0 |
| EBITDA | $0 | – | $0 | -$0 |
| % Margin | 11.7% | – | 24.8% | -1.4% |